Filing Details
- Accession Number:
- 0001179110-18-010878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-24 16:25:05
- Reporting Period:
- 2018-08-23
- Accepted Time:
- 2018-08-24 16:25:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682735 | C. Amy Peterson | C/O Mourant Ozannes Corporate Services, 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108 | Cmo, Immuno-Oncology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Disposition | 2018-08-23 | 1,108 | $167.54 | 4,661 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-08-23 | 2,300 | $168.94 | 2,361 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-08-23 | 1,400 | $169.75 | 961 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-08-23 | 961 | $170.46 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 194,569 | Direct |
Footnotes
- Each American Depositary Share represents 13 Ordinary Shares.
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.05 to $167.77, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.25 to $169.24, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.27 to $170.19, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.30 to $170.87, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Billionaire Hedge Funds
